Figure 2. The prognostic significance of lymphocyte to monocyte ratio (LMR) in overall survival (OS).
A combined analysis showed that LMR lower than the cutoff was associated with poor OS in non-hematological malignancy (HR: 0.59, 95% CI: 0.53–0.66; P < 0.001) and hematological malignancy (HR: 0.44, 95% CI: 0.34–0.56; P < 0.001) with significant heterogeneity (I2 = 53.6% and 77.9%, respectively).